Practicality of <i>STAT3</i> Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma

<div>Relationship between the median sorafenib concentration and HFSR onset (a) and severity (b). HFSR, hand-foot skin reaction; sorafenib <i>C</i><sub>median</sub>, median sorafenib concentration for the study period.</div>

Journal of Clinical Pharmacy and Therapeutics

fig3

Figure 3

Figure 3: Practicality of <i>STAT3</i> Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma 

Figure 3 | Practicality of STAT3 Gene Polymorphisms and Sorafenib Trough Concentration as Biomarkers for Sorafenib-Induced Hand-Foot Skin Reaction in Hepatocellular Carcinoma 